ChemicalBook > CAS DataBase List > YHO-13177

YHO-13177

Product Name
YHO-13177
CAS No.
912287-56-0
Chemical Name
YHO-13177
Synonyms
CS-2881;YHO-13177;YHO-13177, 10 mM in DMSO;BCRP Inhibitor III, YHO-13177;BCRP,YHO-13177,Inhibitor,ABCG2,Breast cancer resistance protein,inhibit;(Z)-2-(3,4-Dimethoxyphenyl)-3-(5-(4-hydroxypiperidin-1-yl)thiophen-2-yl)acrylonitrile;Benzeneacetonitrile, α-[[5-(4-hydroxy-1-piperidinyl)-2-thienyl]methylene]-3,4-dimethoxy-, (αZ)-
CBNumber
CB83035212
Molecular Formula
C20H22N2O3S
Formula Weight
370.47
MOL File
912287-56-0.mol
More
Less

YHO-13177 Property

Boiling point:
577.4±50.0 °C(Predicted)
Density 
1.266±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: 100mg/mL
form 
Solid
pka
14.78±0.20(Predicted)
color 
Light yellow to yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-3968
Product name
YHO-13177
Purity
98.40%
Packaging
5mg
Price
$100
Updated
2021/12/16
ChemScene
Product number
CS-3968
Product name
YHO-13177
Purity
98.40%
Packaging
10mg
Price
$150
Updated
2021/12/16
ChemScene
Product number
CS-3968
Product name
YHO-13177
Purity
98.40%
Packaging
50mg
Price
$450
Updated
2021/12/16
ChemScene
Product number
CS-3968
Product name
YHO-13177
Purity
98.40%
Packaging
100mg
Price
$750
Updated
2021/12/16
DC Chemicals
Product number
DC9369
Product name
YHO-13177
Purity
>98%
Packaging
100mg
Price
$450
Updated
2021/12/16
More
Less

YHO-13177 Chemical Properties,Usage,Production

Uses

YHO-13177, a acrylonitrile derivative, is an orally active, potent and specific inhibitor of breast cancer resistance protein (BCRP) and ABCG2 with an IC50 value of 10 nM. YHO-13177 potentiates the cytotoxicity of SN-38 in HCT116 and A549 cells that express BCRP. YHO-13177 combined with Irinotecan (HY-16562) significantly suppresses the tumor growth in an HCT116/BCRP xenograft model[1][2][3].

Synthesis

93-17-4

207290-72-0

912287-56-0

GENERAL STEPS: 5-(4-hydroxypiperidin-1-yl)-2-thiophenecarboxaldehyde and 3,4-dimethoxybenzeneacetonitrile were placed in a reactor and dissolved in ethanol. After addition of sodium ethoxide, the mixture was stirred under reflux conditions. After completion of the reaction, the reaction mixture was cooled with flowing water for tens of minutes. Water was added to the cooled mixture and stirring was continued for tens of minutes. The precipitated crystals were collected by filtration, washed sequentially with water, ethanol and hexane, and then dried under reduced pressure to give (Z)-2-(3,4-dimethoxyphenyl)-3-[5-(4-hydroxypiperidin-1-yl)thiophen-2-yl]acrylonitrile. Using 5-bromothiophene-2-carbaldehyde (42.30 g) and 4-hydroxypiperidine (67.30 g), an amination reaction was carried out according to Preparation Step 1 to obtain 5-(4-hydroxypiperidin-1-yl)-2-thiophenecarboxaldehyde (yield: 33.00 g, 71%). The prepared 5-(4-hydroxypiperidin-1-yl)-2-thiophenecarboxaldehyde (10.56 g) was subjected to condensation reaction with 3,4-dimethoxyphenylacetonitrile (8.86 g) according to the preparation step 2 to obtain (Z)-2-(3,4-dimethoxyphenyl)-3-[5-(4-hydroxypiperidin-1-yl)thiophen-2-yl]acrylonitrile (yield: 13.50 g, 73%). The obtained (Z)-2-(3,4-dimethoxyphenyl)-3-[5-(4-hydroxypiperidin-1-yl)thiophen-2-yl]acrylonitrile (20.00 g) was dissolved in chloroform (650 mL), and reacted with pyridine (6.41 g) and bromoacetyl bromide (14.13 g) according to Preparation Step 3 (Method A) to obtain bromoacetic acid 1-[5-[(Z)-2- cyano-2 -(3,4-dimethoxyphenyl)vinyl]thiophen-2-yl]piperidin-4-yl ester (yield: 23.00 g, 87%). The prepared 1-[5-[(Z)-2-cyano-2-(3,4-dimethoxyphenyl)vinyl]thiophen-2-yl]piperidin-4-yl ester of bromoacetic acid (2.30 g) was dissolved in chloroform (100 mL), and was reacted with piperidine (533 mg) and triethylamine (658 mg) according to Preparation Step 4 to give (Z)-2-(3,4-dimethoxyphenyl)-3-(5 -(4-hydroxypiperidin-1-yl)thiophen-2-yl)acrylonitrile (Yield: 1.40 g, 60%).

in vivo

YHO-13177 (19.7μM, i.v., or 27.3μM, p.o., a single dose for 25 days) is converted by YHO-13351, increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppresses the tumor growth in an HCT116/BCRP xenograft mouse model[1].

Animal Model:HCT116/BCRP xenograft mouse model[1]
Dosage:19.7 μM or 27.3 μM
Administration:19.7 μM, i.v., or 27.3 μM, p.o., a single dose for 25 days
Result:Was maintained for at least 8 hours in plasma.

References

[1] Yamazaki R, et al. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo. Mol Cancer Ther. 2011 Jul;10(7):1252-63. DOI:10.1158/1535-7163.MCT-10-0874
[2] Shishido Y, et al. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan. Anticancer Res. 2013 Apr;33(4):1379-86. PMID:23564776
[3] Yu S, et al. The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents. Bioorg Med Chem. 2023 Nov 15;95:117486. DOI:10.1016/j.bmc.2023.117486

YHO-13177 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

YHO-13177 Suppliers

Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4757
Advantage
55
ShangHai Angti Biotechnology Co., Ltd.
Tel
13764913901
Fax
-
Email
info@angtibio.com
Country
China
ProdList
4986
Advantage
55
Wuhan Greatwall chemical Co,.LTD
Tel
400-027-6116 18086000087
Fax
QQ: 2680733325
Email
sales@chemgreatwall.com
Country
China
ProdList
1559
Advantage
55
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Fax
022-23754520
Email
klq@cw-bio.com
Country
China
ProdList
8011
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9119
Advantage
58
Shanghai SuperLan Chemcial Technique Centre
Tel
0-2022843681 15618226720
Fax
+86-21-51601218
Email
chaolaichem@foxmail.com
Country
China
ProdList
12476
Advantage
58
More
Less

View Lastest Price from YHO-13177 manufacturers

Career Henan Chemical Co
Product
YHO-13177 912287-56-0
Price
US $1.00/g
Min. Order
1g
Purity
99%
Supply Ability
200kg
Release date
2019-12-25

912287-56-0, YHO-13177Related Search:


  • YHO-13177
  • CS-2881
  • Benzeneacetonitrile, α-[[5-(4-hydroxy-1-piperidinyl)-2-thienyl]methylene]-3,4-dimethoxy-, (αZ)-
  • (Z)-2-(3,4-Dimethoxyphenyl)-3-(5-(4-hydroxypiperidin-1-yl)thiophen-2-yl)acrylonitrile
  • BCRP,YHO-13177,Inhibitor,ABCG2,Breast cancer resistance protein,inhibit
  • YHO-13177, 10 mM in DMSO
  • BCRP Inhibitor III, YHO-13177
  • 912287-56-0